Thu.May 25, 2023

article thumbnail

Two Lawsuits Allege Iowa Medicaid Did Not Provide Proper Mental Health Care

Drug Topics

Iowa's Department of Health and Human Services, which manages the two health insurers that delivered care to adults and children in the state’s Medicaid program last year, was alleged to provide inadequate mental and behavioral health care to children on Medicaid.

Insurance 187
article thumbnail

New calculator demonstrates how improved adherence to anti-diabetic medicines can benefit people in Medicaid

PhRMA

Diabetes is a scary diagnosis for anyone. When people with the disease struggle to manage their blood sugar levels, they can experience significant, life-threatening and costly complications such as heart attack, stroke, kidney failure, amputation and blindness. Fortunately, diabetes can be well-managed with comprehensive access to health care services, including medicines.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A National Drug Shortage Creates Care Challenges in Oncology

Drug Topics

A short supply of cisplatin and carboplatin is forcing health care providers to find less effective alternative treatments.

187
187
article thumbnail

Sublingual Vaccine Shows Efficacy in Preventing Recurrent UTIs, Helping to Eliminate Need for Antibiotics

Pharmacy Times

Women with recurrent urinary tract infections (UTIs) are often on and off antibiotics for years, and even decades, as the only treatment available in health systems for treating UTIs.

Vaccines 123
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Appili Therapeutics receives US patent for ATI-1501

Pharmaceutical Technology

Appili Therapeutics has received a US patent for ATI-1501 , a liquid oral reformulation of metronidazole. The patent claims for ATI-1501 were published by the US patent and trademark office under US application no. 18/072,154, filed on 30 November 2022. It covers the composition and preparation methods for ATI-1501 until 2039. Metronidazole is a widely used frontline oral treatment for parasitic and anaerobic bacterial infections.

Dosage 105
article thumbnail

Study: Promoting Housing Stability Can Support HIV Care, Viral Suppression

Pharmacy Times

Structural inequalities that contribute to HIV acquisition are known to also contribute to housing stability, and this was apparent in findings regarding race and ethnicity.

122
122

More Trending

article thumbnail

Study: Women Identifying as Lesbian, Bisexual More Likely to Have Worse Cardiovascular Health

Pharmacy Times

Sexual minority populations disproportionately suffer from mental health conditions as well, which could partially impact cardiovascular health, a recent study indicates.

121
121
article thumbnail

Opinion: Adopting the term ‘preaddiction’ would be a serious mistake

STAT

The National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism recently proposed a new addition to the addiction vernacular: “ preaddiction.” The idea is that the word will help identify and intervene on harmful substance use earlier and more effectively. While it’s an admirable goal, the term fails to align with the evidence.

102
102
article thumbnail

FDA Approves Xacduro for Intravenous Use in Individuals With HAI Acinetobacter Infections

Pharmacy Times

Acinetobacter are gram-negative human pathogens that infect individuals who are critically ill, which can result in severe pneumonia and bloodstream infections.

FDA 123
article thumbnail

Why Does Hepatitis C Virus Disproportionately Affect Certain Groups?

Drug Topics

Screening and treating immigrants for hepatitis C virus infection may be instrumental to eliminating the disease in Canada.

98
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Semaglutide With Lifestyle Interventions Shows Benefits for Adolescents With Obesity

Pharmacy Times

The use of semaglutide for adolescents was included in recent pediatric guidelines, though there are few studies assessing the drug in this patient population.

123
123
article thumbnail

STAT+: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals

STAT

WASHINGTON — At a waterfront concert in one of this city’s swankiest neighborhoods, rappers Busta Rhymes and Fat Joe interspersed their hits about love, wealth, and wild parties with mini-lectures about hospitals’ high prices. It was a nostalgia-fueled rager — but it was also a not-so-subtle effort by a billionaire to convince Congress and other policymakers to crack down on the commanding sway of the hospital industry.

article thumbnail

Safety, Savings Start With Medication History

Pharmacy Times

Technicians should take advantage of opportunities to work at a higher level of practice, build their careers.

132
132
article thumbnail

MHRA set to launch biobank pilot to better understand genetics and medicines safety

Hospital Pharmacy Europe

A genetic ‘biobank’ will be launched on 1 June 2023 by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to understand how a patient’s genetic make up can impact the safety of their medicines. Known as the Yellow Card biobank, the biobank will contain genetic data and patient samples and be used by scientists to determine whether a side effect from a medicine was caused by a specific genetic trait.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

FDA Approves Pfizer’s Paxlovid for Treatment of COVID-19 in Adults

Pharmacy Times

This marks the fourth drug, and first oral antiviral pill, approved by the FDA to treat adults with mild-to-moderate COVID-19.

FDA 120
article thumbnail

STAT+: Bristol drug reduces reliance on transfusions for people with chronic blood disorder

STAT

In a study reported Thursday, a medicine from Bristol Myers Squibb nearly doubled the treatment benefit compared to standard therapy for certain patients with a chronic blood disorder called myelodysplastic syndrome — results that could change the way physicians care for these patients. Myelodysplastic syndrome, or MDS, is a cancer-like disease of the bone marrow that results in decreased production of healthy blood cells.

97
article thumbnail

Targeting a Newly Identified Gene in the Brain May Reduce Anxiety

Pharmacy Times

Anxiety disorders create social and economic burdens as the availability of effective anxiolytic treatments are low.

123
123
article thumbnail

U.S. Supreme Court rejects Teva challenge to $235M GSK award in patent dispute over generic drugs involving Coreg

Drug Store News

The case involves "skinny labels," which allow generic drugmakers to avoid patent lawsuits if a generic drug's label omits potentially infringing uses of a brand-name drug, per a Reuters report.

article thumbnail

Medication Acquisition Programs Can Improve Access to Treatment

Pharmacy Times

Research has shown these programs can increase the number of patients who can access targeted treatments.

123
123
article thumbnail

Valproate decision support tools launched by NHS England

Hospital Pharmacy Europe

Decision support tools to help clinicians and patients decide whether or not valproate is the right option for them have been launched by NHS England. In efforts to maintain patient safety and curb inappropriate prescribing of valproate during pregnancy, the tools are aimed at women, girls and anyone who could become pregnant, aged between 12 and 55, who are considering or taking valproate for epilepsy or bipolar disorder.

article thumbnail

ElevateBio raises funds to advance cell and gene therapies

Pharmaceutical Technology

ElevateBio has raised $401m in a Series D financing round for advancing its technology platforms to expedite the design, production and development of cell and gene therapies. The technology platforms include the Life Edit gene editing platform, an RNA, cell, protein, vector engineering and induced pluripotent stem cells (iPSCs) platform. ElevateBio intends to use the funds to advance its genetic medicine current good manufacturing practice (cGMP) and process development business, BaseCamp.

97
article thumbnail

STAT+: U.K. unveils $800 million package to bolster life sciences amid concern over biopharma investments

STAT

LONDON — The U.K. government on Thursday unveiled an $800 million package to bolster the life sciences, highlighting officials’ efforts to grow the industry even as biopharma companies have raised alarms about policies they say are deterring them from investing further in the country. The initiative includes a $190 million infusion into the U.K.

article thumbnail

3 reasons pharmacists will meet evolving community healthcare needs

Drug Store News

Pharmacists are well-positioned to deliver what’s needed to meet the clinical and economic burdens of community healthcare, particularly when it comes to diabetes care.

98
article thumbnail

STAT+: Illumina shareholders elect one Icahn ally to board, as company holds off broader challenge

STAT

Shareholders in the DNA-sequencing firm Illumina on Thursday voted to replace the company’s chairman with a candidate put forward by the activist investor Carl Icahn, even as Illumina held off an effort to oust other directors, including CEO Francis deSouza. Andrew Teno, a portfolio manager at Icahn Capital, will replace John Thompson, the former CEO of software firm Symantec and until now Illumina’s chairman.

95
article thumbnail

FDA Approves Celltroin’s Yuflyma as Humira Biosimilar for 8 Disease States

Pharmacy Times

It is Celltrion’s first biosimilar and the second anti-TNFα biosimilar approved for use in the US.

FDA 123
article thumbnail

STAT+: Gilead and Teva defend antitrust claims that prices for HIV medicines were unfairly kept high

STAT

Amid concern that HIV prevention pills are not being widely taken by those at highest risk of infection, AIDS activists hope that a trial getting underway in a federal courtroom this week will help explain why the medicine has struggled to see uptake. The litigation accuses Gilead Sciences of using a range of controversial business tactics that led the U.S. health care system to overspend for HIV medicines.

95
article thumbnail

Does Intermittent Fasting Work?

Pharmacy Times

Eating regimen shows many health benefits, but the diet may not be appropriate for all patients.

123
123
article thumbnail

Opinion: Opportunistic CT: There’s gold in them there images

STAT

More than 80 million CT scans are performed each year in the U.S. alone. In fact, most Americans have had a CT scan by the time they reach age 60, and many will have had several scans. While CT scans often provide key information for diagnosing a certain problem, our current approach leaves an immense amount of information unmined. Given the cost and radiation involved in CT scanning, we have an obligation not to leave any useful data on the metaphorical cutting room floor.

95
article thumbnail

Johnson & Johnson takes another step in CAR-T race with Bristol Myers in multiple myeloma

Fierce Pharma

Johnson & Johnson takes another step in CAR-T race with Bristol Myers in multiple myeloma kdunleavy Thu, 05/25/2023 - 10:52

114
114
article thumbnail

How Medicare’s Aduhelm decision revived old questions about new drugs

STAT

This article is adapted from the latest STAT Report: Decoding Medicare: 10 key coverage decisions and how they’re made. M edicare’s decision to withhold coverage for Biogen’s Aduhelm despite the Food and Drug Administration’s approval of the Alzheimer’s drug has revived longstanding questions about how the federal program determines whether it will pay for new drugs and devices.

95
article thumbnail

How the Part D out-of-pocket cap could benefit people switching from commercial insurance

Fierce Healthcare

How the Part D out-of-pocket cap could benefit people switching from commercial insurance fdiamond Thu, 05/25/2023 - 16:44

Insurance 113
article thumbnail

Listen: ChatGPT in medicine, a boom in weight loss pills, & Sarepta at the FDA

STAT

Can AI diagnose a disease? Are Wegovy’s days numbered? And what makes AI hallucinate? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. As hospitals and health care companies are racing to implement large language models like ChatGPT into their businesses, STAT reporter Casey Ross joins us to explain what experts want the world to know before embracing generative AI.

article thumbnail

8 Ways to Reduce Medication Errors at Your Pharmacy

Digital Pharmacist

Medication errors have the potential to occur frequently and when we least expect them. Whether it be human error involved in filling the prescription or dispensing it, they can happen at any stage in the process. According to the National Institute of Health. Each year, in the United States alone, 7,000 to 9,000 people die as a result of a medication error By prioritizing patient safety and adopting proactive measures, pharmacies can significantly reduce medication errors – saving lives in the

article thumbnail

Apellis scraps pegcetacoplan development in ALS after phase 2 trial flop

Fierce Pharma

Apellis scraps pegcetacoplan development in ALS after phase 2 trial flop zbecker Thu, 05/25/2023 - 10:42

117
117